Hantavirus infections in the United States: Diagnosis and treatment

Advances in Experimental Medicine and Biology

Volumn 394, Issue , 1996, Pages 153-162

  Mertz, Gregory ^b   Chapman, Louisa ^b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RIBAVIRIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; ANEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; EXTRACORPOREAL OXYGENATION; FEMALE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; HYPERAMYLASEMIA; HYPOVOLEMIC SHOCK; INTRAVENOUS DRUG ADMINISTRATION; LACTIC ACIDOSIS; LASSA VIRUS; MALE; PANCREATITIS; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION;

CONVICT CREEK 107 VIRUS; HANTAVIRUS; LASSA VIRUS;

EID: 0029911806     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4757-9209-6_16     Document Type: Conference Paper

References (28)

1. Johnson KM. Ribavirin treatment of arenavirus, hantavirus, pneumo-virus and paramyxovirus disease topical and systemic therapy. In Mills J, Corey L (eds) Antiviral Chemotherapy: New Directions for Clinical Application and Research, Vol. 3. PTR Prentice Hall, Englewood Cliffs, New Jersey, p 229-249, 1993.
2. McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986;314:20-26.
3. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991;164:1119-1127.
4. Hjelle B, Jenison S, Mertz G, et al. Emergence of hantaviral disease in the southwestern United States. West J Med 1994;161:467-73.
5. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. N Engl J Med 1994;330:949-955.
6. Outbreak of acute illness - southwestern United States, 1993. MMWR 1993;42:421-424.
7. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993;262:914-917.
8. Spiropoulou CF, Morzunov S, Feldmann H, et al. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994;200:715-723.
9. Hjelle B, Jenison S, Torrez-Martinez N, et al. A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: Evolutionary relationships to known hantaviruses. J Virol 1994;68:592-596.
10. Nerurkar VR, Song K-J, Gajdusek DC, Yanagihara R. Genetically distinct hantavirus in deer mice. Lancet 1993;342:1058-1059.
11. Nerurkar VR, Song K-J, Song JW, et al. Genetic evidence for a hantavirus enzootic in deer mice (Peromyscus maniculatus) a decade before the recognition of hantaviral pulmonary syndrome. Virology 1994;204:563-568.
12. Elliott LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 1994;51:102-108.
13. Schmaljohn AL, Li D, Negley DL, Bressler DS, Turell MJ, Korch GW, Ascher MS, Schmaljohn CS. Isolation and initial characterization of a newfound hantavirus from California. Virology 1995;206:963-72.
14. Childs JE, Ksiazek TG, Spiropoulou CF, et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 1994;169:1271-1280.
15. Update: Hantavirus disease - United States, 1993. MMWR 1994;42:612-614.
16. Newly identified hantavirus - Florida, 1994. MMWR 1994;43:99,105.
17. Hjelle B, Chavez-Giles F, Torrez-Martinez N, et al. Genetic identification of a novel hantavirus of the harvest mouse Reithrodontomys megalotis. J Virology 1994;68:6751-6754.
18. Wilson C, Hjelle B, Jenison S. Probable hantavirus pulmonary syndrome that occurred in New Mexico in 1975. Ann Intern Med 1994;120:813.
19. Goodman RA, Zaki S, Khan A, et al. Hantavirus pulmonary syndrome in 1978. Abstract H112a, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4-7 October 1994.
20. Zeitz PS, Butler JC, Cheek JE, Samuel MC, Childs JE, Shands LA, et al. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. Journal of Infectious Diseases 1995;171:864-70.
21. Hallin GW, Simpson SQ, Crowell RE, James DS, Koster FT, Mertz GJ, Levy H. Cardiopulmonary manifestations of the hantavirus pulmonary syndrome. Critical Care Medicine 1996;24 (In press).
22. Nolte KB, Feddersen RM, Foucar K, Zaki SR, Koster FT, Madar D, Merlin TL, McFeeley PJ, Umland ET, Zumwalt RE. Hantavirus pulmonary syndrome in the United States: a pathologic description of a disease caused by a new agent. Human Pathology. 1995;26:110-20.
23. Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to Four Corners hantavirus infections among patients with hantavirus pulmonary syndrome J Virology 1994;68:3000-3006.
24. CDC. Progress in the development of hantavirus diagnostic assays - United States MMWR 1993;42:770-1.
25. Butler J, Peters CJ. Hantaviruses and hantavirus pulmonary syndrome Clin Infect Dis 1994;19:387-95.
26. Hjelle B, Spiropoulou CF, Torrez-Martinez N, et al. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome J Infect Dis 1994;170:1013-7.
27. Ketai LH, Williamson MR, Telepak RJ, et al. Hantavirus pulmonary syndrome: Radiographic findings in 16 patients. Radiology 1994;191:665-668.
28. Chapman LE, Mertz G, Kahn AS, et al. Open label intravenous ribavirin for hantavirus pulmonary syndrome. Abstract Hill, Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 4-7 October, 1994.